Title:
ANTI-OX40 ANTIBODY AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2019/144677
Kind Code:
A1
Abstract:
Provided by the present invention is an anti-OX40 antibody. In addition, further provided by the present invention are a nucleic acid sequence that encodes the antibody, a vector comprising the nucleic acid sequence, and a host cell that is transformed or transfected by using the vector. Furthermore, provided by the present invention is a pharmaceutical use of the antibody.
Inventors:
NING JINYING (CN)
HAO FENG (CN)
HE FENG (CN)
NING MINGXUAN (CN)
HAO FENG (CN)
HE FENG (CN)
NING MINGXUAN (CN)
Application Number:
PCT/CN2018/115109
Publication Date:
August 01, 2019
Filing Date:
November 13, 2018
Export Citation:
Assignee:
KYINNO BIOTECHNOLOGY BEIJING CO LTD (CN)
International Classes:
A61K39/395; C07K16/28; A61P35/00; A61P35/02; C12N15/13; G01N33/574
Foreign References:
| CN105229032A | 2016-01-06 |
Other References:
MAO, HUI ET AL.: "Preparation of Anti-Human OX40 Agonist Monoclonal Antibody and Its Biological Function", CURRENT IMMUNOLOGY, vol. 30, no. 3, 31 December 2010 (2010-12-31), pages 195 - 201
Attorney, Agent or Firm:
LEADING INTELLECTUAL PROPERTY FIRM (CN)
Download PDF: